Literature DB >> 974992

Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma).

H D Appleman, E B Helwig.   

Abstract

A series of 127 surgical specimens of epithelioid leiomyomatous tumors (leiomyoblastomas) of the gastric wall from the files of the Armed Forces Institute of Pathology (AFIP) were studied as to biologic behavior, morphogenesis, and histologic features of value in distinguishing benign and malignant variants. These tumors affect middle-aged men primarily and usually present with upper gastrointestinal bleeding or peptic ulcer-like symptoms. They are composed of a mixture of round epithelioid and spindle cells, many of which have clear cytoplasm. The cells are ensheathed by delicate reticular fibers. The presence of a perithelial or glomoid pattern in some tumors suggests a possible relationship to angiomyoma, glomus tumors, and "pericytoma." The epithelioid leiomyoma, the benign form, often arises in the mid- and distal stomach, especially on the anterior wall. Microscopically, it is recognized by the presence of large epithelioid cells and infrequent mitotic figures. Of 103 epithelioid leiomyomas, only one metastasized and thus was biologically malignant. The epithelioid leiomyosarcoma often arises in the proximal stomach and also distally, especially on the posterior wall. Two histologic types of epithelioid leiomyosarcoma are distinguished from the benign epithelioid leiomyoma by the small size of the cells and occasional higher mitotic counts. One sarcoma variant is a small cell caricature of the leiomyoma. The other is more anaplastic, assoicated with a loss of reticular fibers surrounding the cells and an alveolar arrangement. Epithelioid leiomyosarcomas are the most common type of gastric sarcoma. They are aggressive neoplasms; 63% metastasized, usually within 2 years after diagnosis.

Entities:  

Mesh:

Year:  1976        PMID: 974992     DOI: 10.1002/1097-0142(197608)38:2<708::aid-cncr2820380215>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  33 in total

1.  Spontaneous Peritoneal Rupture of Gastric Stromal Tumor.

Authors:  Kutay Sağlam; Serdar Topaloğlu; Mithat Kerim Arslan; Sevdegül Mungan; Adnan Çalık
Journal:  J Gastrointest Cancer       Date:  2017-03

2.  [Sarcoma of the gastrointestinal tract].

Authors:  H J Klomp; C Zornig
Journal:  Langenbecks Arch Chir       Date:  1990

3.  [Diagnosis and therapy of leiomyoma of the upper gastrointestinal tract].

Authors:  F A Wenger; C A Jacobi; H U Zieren
Journal:  Langenbecks Arch Chir       Date:  1996

4.  Epithelioid leiomyosarcoma of uterus.

Authors:  Aparna Setia; Shalini Kanotra; Ritika Aggarwal; Dilip Prabhakarrao Bhavthankar
Journal:  BMJ Case Rep       Date:  2012-04-02

5.  Smooth muscle tumours of the alimentary tract.

Authors:  T Diamond; M H Danton; T G Parks
Journal:  Ann R Coll Surg Engl       Date:  1990-09       Impact factor: 1.891

6.  Sonography of exophytic gastrointestinal leiomyosarcoma.

Authors:  B R Subramanyam; E J Balthazar; B N Raghavendra; M R Madamba
Journal:  Gastrointest Radiol       Date:  1982

7.  Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases.

Authors:  Lizhi Zhang; Thomas C Smyrk; William F Young; Constantine A Stratakis; J Aidan Carney
Journal:  Am J Surg Pathol       Date:  2010-01       Impact factor: 6.394

8.  Gastrointestinal sarcomas. Analysis of prognostic factors.

Authors:  P C McGrath; J P Neifeld; W Lawrence; S Kay; J S Horsley; G A Parker
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

9.  Gastrointestinal lymphoma and sarcoma. A case for aggressive search and destroy.

Authors:  R B Adkins; H W Scott; J L Sawyers
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

10.  Prognostic factors in primary gastrointestinal leiomyosarcoma: a retrospective study.

Authors:  H Kimura; Y Yonemura; N Kadoya; T Kosaka; K Miwa; I Miyazaki; T Sawa; S Yoshimitsu; Y Nishida; T Kamata
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.